AU2003302625A1 - Silicon compounds useful in cancer therapy - Google Patents

Silicon compounds useful in cancer therapy

Info

Publication number: AU2003302625A1
Authority: AU; Australia
Prior art keywords: cancer therapy; compounds useful; silicon compounds; silicon; useful
Prior art date: 2002-11-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003302625A

Inventor

William Bains

John Gary Montana

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Paradigm Therapeutics Ltd

Original Assignee

Amedis Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-29

Filing date

2003-11-20

Publication date

2004-06-23

2003-11-20 Application filed by Amedis Pharmaceuticals Ltd filed Critical Amedis Pharmaceuticals Ltd

2004-06-23 Publication of AU2003302625A1 publication Critical patent/AU2003302625A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)

AU2003302625A 2002-11-29 2003-11-20 Silicon compounds useful in cancer therapy Abandoned AU2003302625A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0227906.5A GB0227906D0 (en)	2002-11-29	2002-11-29	Compounds and their use
GB0227906.5		2002-11-29
PCT/GB2003/005056 WO2004050666A1 (en)	2002-11-29	2003-11-20	Silicon compounds useful in cancer therapy

Publications (1)

Publication Number	Publication Date
AU2003302625A1 true AU2003302625A1 (en)	2004-06-23

Family

ID=9948795

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003302625A Abandoned AU2003302625A1 (en)	2002-11-29	2003-11-20	Silicon compounds useful in cancer therapy

Country Status (3)

Country	Link
AU (1)	AU2003302625A1 (en)
GB (1)	GB0227906D0 (en)
WO (1)	WO2004050666A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1919929A4 (en) *	2005-08-03	2008-08-06	Rnd Pharmaceuticals Inc	Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs
US10479807B2 (en)	2014-10-08	2019-11-19	Epigenetics Phrama LLC	Silylated pyrimidine prodrugs and methods of their use
JP6162349B1 (en)	2016-04-21	2017-07-12	大原薬品工業株式会社	Sacyl moiety silyl ether derivatives of 5-azacytidines
US10227374B2 (en)	2016-04-21	2019-03-12	Ohara Pharmaceutical Co., Ltd.	Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety
WO2017183215A1 (en) *	2016-04-21	2017-10-26	大原薬品工業株式会社	Sugar moiety silyl ether derivative of 5-azacytidine
WO2018230479A1 (en) *	2017-06-13	2018-12-20	大原薬品工業株式会社	5'-position silyl ether derivative for nucleoside anti-cancer agent or anti-virus agent

2002
- 2002-11-29 GB GBGB0227906.5A patent/GB0227906D0/en not_active Ceased
2003
- 2003-11-20 AU AU2003302625A patent/AU2003302625A1/en not_active Abandoned
- 2003-11-20 WO PCT/GB2003/005056 patent/WO2004050666A1/en not_active Ceased

Also Published As

Publication number	Publication date
GB0227906D0 (en)	2003-01-08
WO2004050666A1 (en)	2004-06-17

Similar Documents

Publication	Publication Date	Title
AUPS054702A0 (en)	2002-03-07	Cancer therapy
AU2003209594A1 (en)	2003-09-22	Quinazoline compounds useful in therapy
AU2003224654A1 (en)	2003-09-29	Photodynamic therapy for pre-melanomas
AU2003213144A1 (en)	2003-09-09	Alkylating agent combinations in the treatment of cancer
AU2003224076A1 (en)	2003-11-03	Antibody combination useful for tumor therapy
AU2003212634A1 (en)	2003-09-22	Compounds useful in the treatment of cancer
AUPS236102A0 (en)	2002-06-13	Grinder
EP2561887B8 (en)	2016-12-21	Cancer therapy sensitizer
EP1594433A3 (en)	2005-10-20	Cancer therapy sensitizer
AU2003247005A1 (en)	2004-02-02	Therapy combination
AU2003222449A1 (en)	2003-10-27	Medicine for treating cancer
AU2003245794A1 (en)	2003-09-04	Glycosaminoglycan-dnase combination therapy
AU2003223538A1 (en)	2003-10-27	Methods for the treatment of cancer
AU2003215150A1 (en)	2003-09-02	Therapeutic compounds
AU2003302625A1 (en)	2004-06-23	Silicon compounds useful in cancer therapy
AU2003283339A1 (en)	2004-06-07	Cancer therapy determination
AU2003285079A1 (en)	2004-06-07	Neurostimulation therapy manipulation
GB0329693D0 (en)	2004-01-28	Compounds useful in therapy
AU2002351382A1 (en)	2003-06-23	Combination cancer therapy
GB2383538B (en)	2003-11-19	Cancer treatment
AU2003223317A1 (en)	2003-11-03	Determining cancer aggressiveness
AU2003231937A1 (en)	2003-12-19	Therapeutic methods
AU2003247094A1 (en)	2004-02-09	Enhancing the effect of radioimmunotherapy in the treatment of tumors
AU2002353346A1 (en)	2004-04-30	Induced remission therapy
HK1074205A (en)	2005-11-04	Porphyrin-polyamine conjugates for cancer therapy

Legal Events

Date	Code	Title	Description
2005-09-22	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase